Impact of gender on outcomes of patients with multiple myeloma undergoing autologous Haematopoietic stem cell transplant

Br J Haematol. 2023 May;201(4):e37-e41. doi: 10.1111/bjh.18753. Epub 2023 Mar 14.

Authors

Oren Pasvolsky^{1

2

3}, Rima M Saliba¹, Adeel Masood¹, Ali H Mohamedi¹, Mark R Tanner¹, Qaiser Bashir¹, Samer Srour¹, Neeraj Saini¹, Jeremy Ramdial¹, Yago Nieto¹, Hans C Lee⁴, Krina K Patel⁴, Partow Kebriaei¹, Sheeba K Thomas⁴, Donna M Weber⁴, Robert Z Orlowski⁴, Elizabeth J Shpall¹, Richard E Champlin¹, Muzaffar H Qazilbash¹

Affiliations

¹ Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
² Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel.
³ Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
⁴ Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.

PMID: 36916461
DOI: 10.1111/bjh.18753

No abstract available

Publication types

Letter

MeSH terms

Hematopoietic Stem Cell Transplantation* / adverse effects
Humans
Multiple Myeloma* / etiology
Multiple Myeloma* / therapy
Transplantation, Autologous